共 90 条
[1]
Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[2]
Miller KD(2021)Pancreatic cancer: a review JAMA 326 851-862
[3]
Fuchs HE(2021)Updates on the management of pancreatic cancer Surg Oncol Clin N Am 393 1819-1830
[4]
Jemal A(2019)Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Lancet 369 134-144
[5]
Park W(2013)Safety and tumor responses with lambrolizumab (anti-PD1) in melanoma N Engl J Med 363 711-723
[6]
Chawla A(2010)Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 383 2207-2218
[7]
O'Reilly EM(2020)Pembrolizumab in microsatellite-instability-high advanced colorectal cancer N Engl J Med 18 1182-1191
[8]
Tsai S(2017)Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Lancet Oncol 40 135-153
[9]
Evans DB(2020)Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy Cancer Commun 38 1074-1084
[10]
Mok TSK(2017)Comparative analysis of single-cell RNA sequencing methods Mol Cell. 14 847-856